According to the latest report published by Credence Research, Inc. “Short Bowel Syndrome Market – (Drug Type – GLP-2, Glutamine, Growth Hormone and Other Drugs): Market Growth, Future Prospects and Competitive Analysis, 2017-2025,” the market was valued at US$ 315.1 Mn in 2016, and is expected to reach US$ 2,901.0 Mn by 2025, expanding at a CAGR of 27.5% from 2017 to 2025.
The Short Bowel Syndrome Market Research Report Forecast 2017-2025 is an important source of insightful data for market strategists. It presents the Short Bowel Syndrome industry overview with growth analysis and past & futuristic cost, income, demand and supply data (as relevant). The research analysts present a detailed representation of the value chain and its distributor analysis. This Short Bowel Syndrome Market study gives complete data which improves the understanding. [Continue reading…]
Short bowel syndrome is a group of complex diseases that occurs due to malfunction of a portion of small and/or large intestine. The individuals with short bowel syndrome exhibit poor absorption of nutrients such as water, fats, carbohydrates, vitamins, minerals and other vital elements which leads to malnutrition, weight loss. However, in some cases, short bowel syndrome can lead to severe, disabling and life-threatening complications. There is no particular cure to this disorder however surgical removal (resection) of half or more of the small intestine is effective. Short bowel syndrome can lead to Crohn’s disease, injury or trauma to the small intestine. Such complications are making a significant contribution to the growth of the short bowel syndrome market. On the basis of drug the market is segmented into GLP-2, glutamine, growth hormone and others. GLP-2 currently holds the largest market in terms of drug in the short bowel syndrome market as it is marketed in U.S. and Europe under the brand name Gattex and Revestive in Europe and other international market. The drugs currently holds the orphan drug status, and the exclusivity of the drugs in the treatment of the short bowel syndrome would further draw huge revenue during the forecast period.
Browse the full report at https://www.credenceresearch.com/report/short-bowel-syndrome-market
The qualitative study of drivers and limitations of Short Bowel Syndrome Market
Key players in the global Short Bowel Syndrome Market Include Merck KGaA, and Emmaus Life Sciences, Inc, Nutrinia Ltd, GlyPharma Therapeutics, OxThera, Ardelyx, Inc, and others.
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/58584
Reasons to Buy
Gain up to date report and analysis about the global Short Bowel Syndrome Market
Recognize key regions and countries that describe potential growth possibilities for the Short Bowel Syndrome Market
Facilitate decision making by understanding the opportunities presented by the Short Bowel Syndrome Market
Gain information about major players in the Short Bowel Syndrome Market
Research methodology and delivery time
Credence Research has conducted in depth secondary research to arrive at key insights. Data collected from key public industry sources and publications have been scanned and analyzed impartially to present a clear picture of the industry. All recent developments which impact the sector dynamics have been captured and used to support the research hypothesis.
The report is available as the single-site single-user license. The delivery time for the electronic version of the report is 3 business days as each copy undergoes thorough quality check and is updated with the most recent information available.
Download Free PDF Request for Customization: https://www.credenceresearch.com/request-for-customization/58584
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Related Reports: https://www.youtube.com/watch?v=6t33E4PeLY4&feature=youtu.be
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US